Companies: 48,686 Total Market Cap: 127339687136261.19

Biotoxtech

KOSDAQ-086040
Medical Laboratories
Rank #31736
Market Cap 32.66 M
Volume 13.50
Price 2.19
Change (%) 1.48%
Country or region South Korea South Korea

Biotoxtech's latest marketcap:

32.66 M

As of May 9, 2025, Biotoxtech's market capitalization has reached $32.66 M. According to our data, Biotoxtech is the 31736th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.

Market Cap 32.66 M
Revenue (ttm) 29.31 M
Net Income (ttm) -4,556,911.15
Shares Out 15.72 M
EPS (ttm) -0.30
Forward PE 0.00
Ex-Dividend Date n/a
Earnings Date May 14, 2025
Market Cap Chart
Data Updated: May 9, 2025

Biotoxtech's yearly market capitalization.

Biotoxtech has seen its market value drop from ₩221.83 B to ₩46.06 B since 2020, representing a total decrease of 79.24% and an annual compound decline rate (CAGR) of 30.29%.
Date Market Cap Change (%)
May 9, 2025 ₩46.06 B -10.64%
December 30, 2024 ₩52.43 B -46.56%
December 28, 2023 ₩98.11 B -17.65%
December 29, 2022 ₩119.14 B 1.5%
December 30, 2021 ₩117.38 B -47.08%
December 30, 2020 ₩221.83 B

Company Profile

About Biotoxtech Co., Ltd.

Biotoxtech Co., Ltd. is a South Korean company specializing in the safety evaluation of various products, including:

  • Synthetic medicines
  • Biomedicines
  • Cell therapy products
  • Gene therapy products
  • Health functional foods
  • Chemicals
  • Pesticides

Core Services

The company provides comprehensive services in:

  • Testing and substance screening
  • Clinical pathology and histopathology
  • Consulting and government affairs for non-clinical trials
  • New drug development support

Safety Evaluation Research

Biotoxtech's expertise includes:

  • General toxicity testing
  • Carcinogenicity studies
  • Local toxicity studies
  • Reproductive and developmental studies
  • Genotoxicity testing
  • Immunotoxicity testing
  • Safety pharmacology testing
  • Aquatic ecotoxicology testing
  • Histopathology/clinical pathology
  • Animal testing methodologies

Founded: 2000
Headquarters: Cheongwon, South Korea

Frequently Asked Questions

As of May 9, 2025, Biotoxtech (including the parent company, if applicable) has an estimated market capitalization of $32.66 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.

Biotoxtech global market capitalization ranking is approximately 31736 as of May 9, 2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.

Stock Detail

Country or region South Korea
Founded 2000
IPO Date n/a
Employees 198
CEO Jong-Koo Kang
Sector
Industry Medical Laboratories
Address Ochang Science Industrial Complex
Cheongwon, Chungcheongbuk-do 363-883
South Korea